CORO7에 의한 Hippo 신호전달체계 조절에 관한 연구 by 박진아
 
 
저 시-비 리- 경 지 2.0 한민  
는 아래  조건  르는 경 에 한하여 게 
l  저 물  복제, 포, 전송, 전시, 공연  송할 수 습니다.  
다 과 같  조건  라야 합니다: 
l 하는,  저 물  나 포  경 ,  저 물에 적 된 허락조건
 명확하게 나타내어야 합니다.  
l 저 터  허가를 면 러한 조건들  적 되지 않습니다.  
저 에 른  리는  내 에 하여 향  지 않습니다. 




저 시. 하는 원저 를 시하여야 합니다. 
비 리. 하는  저 물  리 목적  할 수 없습니다. 
경 지. 하는  저 물  개 , 형 또는 가공할 수 없습니다. 
이학석사학위논문
CORO7에 의한 Hippo
신호전달체계 조절에 관한 연구
Molecular functions of CORO7 in







Molecular functions of CORO7 in
regulating Hippo signaling pathway
Jina Park
School of Biological Sciences
The Graduate School
Seoul National University
From Drosophila to mammals, the Hippo pathway plays crucial roles
in control of organ growth and tissue homeostasis. Through rigorous
studies for the last two decades, the core kinase cassette comprised
of two kinases (MST1/2 and LATS1/2) and two scaffolds (SAV1 and
MOB1) has been discovered to be essential for the regulation of
Hippo signaling. However, how and where its formation and
activation happens are not fully understood. Here, I identify that
CORO7 positively regulates the Hippo pathway through the analysis
of protein interaction database and genetic screening in Drosophila. I
demonstrate that CORO7 is necessary for Hippo signaling activation
induced by serum deprivation, contact inhibition and cytoskeleton
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damage. I also show that CORO7 physically interacts with Hippo core
components and functions as a scaffold for the core kinase cassette.
Interaction of CORO7 with SAV1 and MST1/2 is regulated by Hippo
activating signals, suggesting a multi-step binding regulation of
Hippo core kinase cassette by CORO7. My results provide molecular
insights of Hippo signaling regulation and have implications for
understanding Hippo-related diseases.
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The Hippo pathway functions as an essential controller of cell growth
and homeostasis (Fu et al., 2017). Various upstream signals such as
growth factors, mechanical stress and nutrients are identified to
regulate the Hippo pathway (Meng et al., 2016; Panciera et al., 2017;
Yu et al., 2015). This signaling was initially discovered in Drosophila
to restrict organ size and its function is evolutionarily conserved in
higher eukaryotes (Oh and Irvine, 2010). In mammalian system, major
Hippo pathway components include two upstream kinases (MST1/2
and LATS1/2) and two scaffold proteins (SAV1 and MOB1) which
form the core kinase cassette and inhibit YAP, a primary effector of
the pathway (Piccolo et al., 2014; Sudol and Harvey, 2010). When the
Hippo pathway is activated under unfavorable growth condition,
MST1/2 binds and phosphorylates SAV1(Callus et al., 2006; Park and
Lee, 2011). MST1/2 also interacts with MOB1, forming
SAV1-MST1/2-MOB1 complex (Meng et al., 2016; Ni et al., 2015).
LATS1/2 is then recruited to this complex and phosphorylated by
MST1/2 at its hydrophobic motif (HM) (Meng et al., 2016). Although
multiple mechanistic and structural studies on MOB1 revealed its
function as a scaffold (Couzens et al., 2017; Kim et al., 2016a;
Kulaberoglu et al., 2017; Ni et al., 2015; Vrabioiu and Struhl, 2015;
Xiong et al., 2017), how SAV1 precisely regulates protein interactions
of Hippo components is not fully understood. Furthermore, molecular
mechanisms explaining how and where LATS1 is recruited to form
2
the core kinase cassette remain uncertain.
HM-phosphorylated LATS1/2 bound with MOB1 is released from
MST1/2 and MOB1 induces the autophosphorylation of LATS1/2 at
its activation loop, which in turn facilitates LATS activation
(Manning and Harvey, 2015). Finally, LATS1/2 phosphorylates YAP,
which leads its sequestration in the cytoplasm by 14-3-3 and
degradation by β-TRCP E3 ligase complex (Dong et al., 2007; Zhao
et al., 2010; Zhao et al., 2007). Upon dephosphorylation, YAP
translocates to the nucleus and functions as a co-activator of
transcription factors. YAP mainly interacts with and regulates
TEAD1/2/3/4 to induce transcription of genes which promote
proliferation and inhibit apoptosis (Goulev et al., 2008; Wu et al.,
2008; Zhang et al., 2008).
Since the Hippo pathway governs proper cell proliferation and
death, deregulation of this signaling is often associated with human
cancers (Harvey et al., 2013). In mouse studies, tissue-specific
deletion of core Hippo pathway components or overexpression of YAP
gives rise to tumors (Harvey et al., 2013). Furthermore,
downregulation of Hippo components and abnormal activation of YAP
have been widely observed in various human cancers (Mo et al.,
2014). However, the role of the Hippo pathway in tumorigenesis could
be dependent on the cellular contexts of the tumor (Lin et al., 2017).
For instance, YAP has been demonstrated to have tumor-suppressive
effects by inhibiting Wnt signaling in the cytoplasm (Barry et al.,
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2013).
CORO7 belongs to WD40-repeat Coronin protein families (Chan
et al., 2011). While other members of the family contain one, CORO7
has two WD40 domains which are generally believed to function as a
scaffold to support protein-protein interaction (Xu and Min, 2011). In
mammalian cells, CORO7 localizes to cytosol and trans-Golgi network
(TGN) where it has roles in the maintenance of Golgi morphology
and post-Golgi trafficking (Chan et al., 2011; Yuan et al., 2014). A
recent study has shown that poly-ubiquitinated CORO7 is targeted to
TGN and facilitate F-actin assembly and carrier biogenesis (Yuan et
al., 2014). However, the function of cytosolic CORO7 and the role of
its WD40 domains are largely unknown.
In this study, I identified CORO7 as a novel regulator of the
Hippo pathway. Through protein interaction database analysis and
RNAi screening in Drosophila, pod1, an ortholog of CORO7, was
discovered to activate Hippo signaling. In mammalian cells, CORO7
was necessary for the activation of the Hippo pathway in response to
various upstream signals. These findings indicate that CORO7 is a
new member of the Hippo pathway regulating protein interactions
among the core components of the signaling.
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RESULTS
CORO7 is a positive regulator of the activation of
the Hippo pathway in mammalian cells
To identify whether CORO7 regulates the Hippo pathway in the
mammalian system, I examined the roles of CORO7 in Hippo
signaling activation induced by various upstream signals. Previous
research has shown that when the Hippo pathway is activated,
LATS1/2 phosphorylates YAP on its Ser 127, which results in the
inhibition of YAP through its sequestration in the cytoplasm (Zhao et
al., 2007). Serum deprivation induced YAP-S127 phosphorylation in
cells treated with control short interfering RNA (siRNA) while
CORO7 knockdown significantly decreased the levels of this
phosphorylation (Figure 1A). Consistent with this result, serum
deprivation-induced cytoplasmic localization of YAP was also blocked
by silencing of CORO7, indicating the necessity of CORO7 for
repressing YAP (Figure 1B). Furthermore, CORO7 knockdown
impeded Hippo signaling activation by contact inhibition, as shown by
reduced YAP-S127 phosphorylation levels and nuclear YAP
localization (Figure 1C and 1D).
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Figure 1. CORO7 is critical for the activation of the Hippo
pathway in mammalian cells. (A) Control or CORO7-knockdown
MDA-MB-231 cells were deprived of serum and collected for
immunoblotting for the indicated proteins and phosphorylation. (B)
Control or CORO7-knockdown HEK293T cells were cultured in media
with or without serum for 1 h and fixed for immunofluorescence with
YAP antibody. Cell nuclei was stained with DAPI. Scale bars, 10μm.
(C) Equal numbers of control or CORO7-knockdown MDA-MB-231
cells were seeded in 24 well, 12 well, 6 well and 60mm culture plates
to make the different cell density conditions 24 h before collecting and
immunoblotting. (D) Control or CORO7-knockdown HEK293T cells
were cultured under dense monolayer condition and subcellular
localization of endogenous YAP was examined by
immunofluorescence. Scale bars, 10μm. (E and F) The effect of
cytoskeleton damage through Latrunculin B treatment (0.25 μg/ml)
(E) or cell detachment (F) on Hippo signaling was analyzed by
immunoblotting.
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In recent studies, actin cytoskeleton damage was identified to
activate Hippo signaling (Fernandez et al., 2011; Kim et al., 2013;
Sansores-Garcia et al., 2011). As anticipated, YAP-S127
phosphorylation was induced after treatment of Latrunculin B (LatB),
an actin polymerization inhibitor, or cell detachment (Figure 1E and
1F). However, loss of CORO7 diminished this phosphorylation,
suggesting that CORO7 could positively regulate the Hippo pathway
in response to actin cytoskeleton damage (Figure 1E and 1F).
Notably, the levels of LATS1-T1027 phosphorylation induced by
serum deprivation and Latrunculin B were reduced in CORO7
knockdown cells (Figure 1A and 1E). These results suggest that
upon CORO7 knockdown, YAP could not be inhibited due to the
inactivation of LATS1.
To further verify the role of CORO7 in proper Hippo signaling
activation, I generated CORO7 knockout MDA-MB-231 cells using
the CRISPR-Cas9 system. Complete deletion of CORO7 was
confirmed by western blotting with CORO7-specific antibody and
genomic DNA sequencing. CORO7 knockout cells showed decreased
LATS1-T1027 and YAP-S127 phosphorylation levels in response to




Figure 2. Hippo signaling activation is inhibited in CORO7 KO
MDA-MB-231 cells. (A and B) Immunoblots showing the indicated
proteins and phosphorylation in wild-type or CORO7 knockout
MDA-MB-231 cells after serum deprivation (A) or Latrunculin B
treatment (B). The asterisks indicate non-specific bands. (C) mRNA
levels of CTGF and CYR61 were determined by quantitative real-time
PCR and normalized for alpha-actin control. The error bars represent
±s.e.m. from n=5 independent experiments. *P<0.05; **P<0.01;
***P<0.001. Student's t-test was applied. (D) Wild-type or CORO7
knockout MDA-MB-231 cells were co-transfected with pRL-TK
encoding Renilla luciferase and 8X‐TBS (8 repeats of TEAD-binding
sequence) encoding firefly luciferase. 24 h after the transfection, the
cells were collected and subjected to Dual-Luciferase Reporter Assay
(n=3).
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YAP phosphorylation results in the repression of YAP
transcriptional activity. I investigated whether CORO7 affects the
mRNA expression of two YAP target genes, CTGF and CYR61. As
expected, their expression levels increased in CORO7 KO cells
compared to wild-type cells (Figure 2C). This result was also
corroborated by 8X-TBS (8 repeats of TEAD-binding sequence)
luciferase reporter assay (Figure 2D). Collectively, these data
demonstrate that CORO7 is necessary for the activation of the Hippo
pathway under diverse conditions.
Physical interaction of CORO7 with Hippo
pathway components
WD40 domain plays essential roles in several signaling pathways as
a scaffold which facilitates protein-protein interactions (Xu and Min,
2011). Since CORO7 has two highly conserved WD40 domains, I
tested whether it physically interacts with Hippo pathway
components. Surprisingly, CORO7 co-immunoprecipitated with
LATS1/2, MST1/2 and SAV1, but not with AMOT p80, AMOTL1,
AMOTL2, MOB1A, indicating that CORO7 specifically interacts with
a subset of Hippo pathway components (Figure 3A, 3B, 3D, 3E and
3F). To determine which WD40 domain is responsible for these
interactions, I tested the N-terminal half (1-459 amino acids) and the




Figure 3. CORO7 physically interacts with the components of
the Hippo pathway. (A and B) Exogenously expressed AMOT p80,
AMOTL1, AMOTL2 (A) and MOB1A (B) were immunoprecipitated to
examine their interaction with CORO7. (C) Schematic representation
of domains and truncated constructs used in co-immunoprecipitation
assay (co-IP) for CORO7 (D, E and F) Overexpressed HA-LATS1
(D), HA-MST2 (E) and HA-SAV1 (F) were co-immunoprecipitated
with N- or C- terminal half of Flag-CORO7 in HEK293T cells.
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As shown in Figure 3D, 3E and 3F, the C-terminal half of CORO7
containing the second WD40 domain showed stronger interaction with
LATS1, MST2 and SAV1 than the N-terminal half of CORO7.
To examine the domain of SAV1 involved in SAV1-CORO7
binding, I conducted co-immunoprecipitation assay with truncated
forms of SAV1 and found that the N-terminal half of SAV1 (1-202
amino acids) binds to CORO7 (Figure 4A). The C-terminal half of
SAV1 contains two WW domains and SARAH domain, while the
N-terminal half of SAV1 involves FERM-binding motif (FBM,
SAV119-25) which is reported to bind to the FERM domain of NF2
(Figure 4B). I observed that FBM was dispensable for SAV1-CORO7
interaction (Figure 4C). MST1/2 binds to SAV1 through its SARAH
domain and phosphorylates SAV1 on several sites including Thr 26,
Ser 27 and Ser 36 (Park and Lee, 2011) which are included in the
CORO7-binding domain of SAV1. However, the role of this
phosphorylation in the Hippo pathway has not been identified.
Therefore, it is possible that SAV1 phosphorylation by MST1/2 may
affect the interaction between CORO7 and SAV1. Taken together,
these findings suggest that CORO7 binds to N-terminal SAV1.
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Figure 4. CORO7 binds to N-terminal SAV1 and SAV1
promotes CORO7-MST2 interaction. (A) Truncated forms of SAV1
were used for co-IP assay to examine the domain responsible for
CORO7 binding. (B) Schematic representation of domains and motifs
of SAV1 (C) SAV1 deletion mutants of full (ΔGKYMKKD) or part
(ΔGKY) of FERM-binding motif were subjected to co-IP
experiments. (D) MST2 deletion mutant of SARAH domain was
examined for its binding with CORO7. (E) Co-IP assay showed that
co-expression of truncated forms or wild-type SAV1 affected
MST2-CORO7 interaction.
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As SAV1 acts as a scaffold for MST1/2, I next examined
whether the formation of SAV1-MST1/2 complex affects
CORO7-MST2 interaction. Indeed, SARAH domain truncated mutant
of MST2 which cannot bind to SAV1 was defective in interaction
with CORO7 (Figure 4D). Furthermore, co-expression of wild-type
SAV1 enhanced CORO7-MST2 interaction (Figure 4E), suggesting
that binding affinity of MST2 to CORO7 may increase when it forms
a complex with SAV1. I also investigated which domain of SAV1 is
responsible for its function as a scaffold bridging CORO7 and MST2.
Co-immunoprecipitation experiment showed that the N-terminal half
(SAV11-202) which interacts with CORO7 and SARAH domain which
binds to MST2, but not WW domain, were able to increase
CORO7-MST2 interaction (Figure 4E).
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Figure 5. CORO7 is essential for the formation of the core
Hippo kinase complex. (A) LATS1-MST2 interaction with or
without co-expression of SAV1 or MOB1 was examined by
co-immunoprecipitation assay in control or CORO7-knockdown cells.
(B) HA-LATS1, HA-SAV1 and HA-MOB1 co-immunoprecipitated
with Flag-MST2 were observed in wild-type or ΔN37 mutant SAV1
co-expressed HEK293T cells. (C) HA-LATS1 and HA-SAV1
co-immunoprecipitated with Flag-MST2 were observed in control or
CORO7-knockdown cells. (D) HA-MST2 and HA-SAV1
co-immunoprecipitated with Flag-LATS1 were observed in control or
CORO7-knockdown cells.
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CORO7 is important for the formation of the
Hippo core kinase cassette
One of the most important regulatory mechanisms of the Hippo
pathway is sequential phosphorylation. Hippo signaling is transduced
by phosphorylation events of MST1/2-LATS1/2-YAP axis. In this
process, SAV1 and MOB1 promote the formation of the Hippo core
kinase cassette which is consisted of two kinases (MST1/2 and
LATS1/2) and two scaffolds (SAV1 and MOB1). It has been reported
that SAV1 binds to MST1/2 through its SARAH domain to activate
MST1/2 (Scheel and Hofmann, 2003) and interacts with the PPXY
motifs of LATS1/2 through its WW domains (Tapon et al., 2002).
However, a recent structural study showed that binding between
human SAV1 WW domains and a PPXY-containing peptide of
LATS1 is much weaker than pMOB1-LATS1 binding (Ni et al.,
2015). Furthermore, there is no direct evidence for the formation of
MST1/2-SAV1-LATS1/2 ternary complex (Ni et al., 2015). Thus, I
hypothesized that CORO7 could facilitate SAV1-LATS1/2 association
through its binding to both SAV1 and LATS1/2. To examine this
hypothesis, I performed co-immunoprecipitation assay to observe
LATS1-MST2 association. As expected, LATS1 and MST2 were
found to be in the same complex when both SAV1 and MOB1 were
co-expressed (Figure 5A). Of note, SAV1 ΔN37 could not enhanced
LATS1-MST2 interaction as wild-type SAV1, suggesting that
CORO7-binding site on SAV1 is required for its scaffold function
(Figure 5B). In addition, SAV1 ΔN37 could not bind to LATS1
20
(Figure 5B). SAV1 has been reported to bind to LATS1/2 through its
WW domain, however this result indicates that N-terminal 37 amino
acids on SAV1 is also necessary for SAV1-LATS1/2 interaction.
I next tested whether CORO7 is necessary for LATS1-MST2
interaction. Surprisingly, despite SAV1 and MOB1 co-expression,
knockdown of CORO7 completely blocked MST2-LATS1 interaction
while did not affect MST2-SAV1 interaction (Figure 5A and 5C).
Furthermore, silencing of CORO7 decreased the levels of SAV1 and
MST2 co-immunoprecipitated with LATS1 (Figure 5D). Taken
together, these data suggest that CORO7 could act as a scaffold for
LATS1 to interact with SAV1-MST2 complex.
Regulation of CORO7 interaction with Hippo
components by Hippo activating signals
Serum starvation and actin depolymerization are two well-established
Hippo activating signals in mammalian cells. I investigated whether
these stimuli regulate the interaction of CORO7 with SAV1, MST2
and LATS1. Interestingly, when the Hippo pathway was activated by
serum starvation or Latrunculin B, the levels of SAV1 and MST2
co-immunoprecipitated with CORO7 decreased (Figure 6A). In




Figure 6. SAV1 changes its binding partner from CORO7 to
NF2 upon the Hippo pathway activation (A) 24 h after seeded to
15% confluency, HEK293T cells were serum starved or treated with
0.25μg/ml Latrunculin B for 1 h and collected for
co-immunoprecipitation assay examining CORO7-MST2 and
CORO7-SAV1 interaction. (B) Similar co-IP assay was performed to
determine the effect of serum starvation on CORO7-LATS1
interaction. (C) CORO7-SAV1 interaction with the increased levels of
NF2 co-expression was observed by co-IP assay. (D) Similar co-IP
assay as (A) and (B) was performed to determine the effect of serum
starvation on SAV1-CORO7 and SAV1-NF2 interaction. (E) Cells
were subjected to subcellular fractionation and immunoprecipitation to
examine SAV1-CORO7 and SAV1-NF2 interaction in each fraction.
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SAV1 binds to NF2 instead of CORO7 upon the
Hippo pathway activation
Since CORO7-binding site on SAV1 is N-terminus which involves
FBM where NF2 binds (Figure 4A), I hypothesized that CORO7 could
compete with NF2 for interaction with SAV1. Indeed, binding
between SAV1 and CORO7 was reduced along with the increased
expression of NF2 (Figure 6C). Next, I explored the possibility that
the binding partner of the N-terminal SAV1 is regulated by the
Hippo pathway activation. Interestingly, SAV1 prefers to bind to NF2
over CORO7 upon the serum starvation-induced Hippo pathway
activation (Figure 6D). As SAV1 translocates from the cytoplasm to
the membrane in response to serum starvation or Latrunculin B
treatment (Figure 7A and 7B), the binding partner of N-terminal
SAV1 could be dependent on its localization. Thus, I obtained
membrane and cytoplasm fractionation of cells and immunoprecipitated
SAV1 from each fractionation to examine whether it binds to CORO7
or NF2. Indeed, SAV1 preferred to bind to CORO7 in the cytoplasm
fraction, whereas it preferred NF2 in the membrane fraction (Figure
6E). Interestingly, the membrane association of SAV1 and LATS1 in
response to Hippo pathway activation were defective in CORO7
knockout cells, indicating that CORO7 is involved in the
membrane-targeting events of Hippo components (Figure 7A and 7B).
24
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Figure 7. CORO7 is significant for the membrane localization of
Hippo components. (A and B) Wild-type or CORO7 knockout
MDA-MB-231 cells were serum starved (A) or treated with 0.25
μg/ml Latrunculin B for 1 h. Cells were subjected to subcellular
fractionation and western blotting with the indicated antibodies. (C) A




In the present study, CORO7 has been first identified as a positive
regulator of the Hippo pathway. I demonstrate that CORO7 is
required for the activation of Hippo signaling in mammalian cells.
YAP inhibition under Hippo upstream signals is blocked upon the loss
of CORO7. Through its two conserved WD40 domains, CORO7
physically interacts with SAV1, MST1/2 and LATS1/2, three major
Hippo pathway components. Notably, CORO7 is required for the
formation of the Hippo core kinase cassette, indicating its function as
a scaffold protein.
Although CORO7 has two WD40 domains which are reported to
facilitate protein interactions in several signaling pathways, the
scaffold function of CORO7 was previously unknown. I propose that
CORO7 activates Hippo signaling mainly through the regulation of
protein interactions, which is supported by our three findings. First,
CORO7 can interact with three members of the core kinase cassette.
In particular, I mapped the CORO7-binding site on SAV1 where has
been reported to be phosphorylated by MST1/2. Therefore, further
research is necessary to investigate whether CORO7-SAV1 binding is
dependent on this phosphorylation in a similar way that the WD40
domains of β-TRCP and Cdc4 recognize their substrates
phosphorylated on serine and threonine (Hart et al., 1999; Orlicky et
al., 2003; Winston et al., 1999).
27
The second evidence is that CORO7 promotes the formation of
the core kinase cassette by recruiting LATS1 to
SAV1-MST1/2-MOB1 complex. Without CORO7, LATS1/2 is
defective in the interaction with SAV1 and MST1/2. Recently, the
multi-step assembly mechanism of the core kinase cassette was
proposed (Meng et al., 2016). When Hippo signaling is activated,
MST1/2 makes a MOB1-docking site through the autophosphorylation
at its linker region. In addition, MST1/2 also binds and
phosphorylates SAV1. Next, MOB1 binds to MST1/2, which results
in the open formation of MOB1 for LATS1/2. Through an unknown
mechanism, LAT1/2 is recruited to MOB1-MST1/2-SAV1 complex,
which forms the core kinase complex and enables the sequential
phosphorylation of MST1/2-LATS1/2-YAP axis. Our findings suggest
that CORO7 is the scaffold protein that is responsible for the
recruitment of LATS1/2 to form the core kinase cassette through
binding to both LATS1/2 and SAV1.
Finally, I proposed the binding partner switch mechanism of
SAV1, which provides an additional layer of Hippo pathway
regulation. Interestingly, Hippo activating signals weakens
SAV1-CORO7 interaction and strengthens SAV1-NF2 interaction.
Also, CORO7 and NF2 compete to bind N-terminus of SAV1.
Therefore, I suggest that CORO7 regulate the Hippo pathway through
two-step processes. First, CORO7 recruits LATS1/2 to
SAV1-MST1/2-MOB1 complex in the cytoplasm, forming the core
kinase cassette. Second, upon further Hippo activating signals, the
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core kinase cassette translocates to the plasma membrane and CORO7
is released from SAV1, providing the N-terminal SAV1 binding site
for NF2. Our study extends recent research that has identified the
role of NF2-SAV1 interaction in Hippo signaling activation (Yin et
al., 2013).
In addition to its scaffold function, CORO7 affects LATS1
stability upon Hippo activating signals. I demonstrated that when
CORO7 is depleted, LATS1 levels decrease under Hippo
signaling-activated conditions. LATS1 also constitutively binds with
CORO7 regardless of Hippo activating signals. I note that LATS1
stability control by E3 ubiquitin ligases such as ITCH and NEDD4 is
one of the key regulatory mechanisms of Hippo signaling (Ho et al.,
2011; Salah et al., 2013; Salah et al., 2011). Therefore, I speculate that
CORO7 may play a protecting role for LATS1 against Hippo
signaling activation- induced degradation as a negative feedback
mechanism. Furthermore, serum deprivation or cytoskeleton damage
induced-membrane association of Hippo pathway components (SAV1
and LATS1) is blocked in CORO7 knockout cells. It has been
reported that NF2 and SAV1 participate in the membrane association
of LATS1/2 and MST1/2, respectively (Yin et al., 2013). Our results
indicate that CORO7 is also involved in the membrane targeting of
Hippo pathway components. Abnormal formation of the core kinase
cassette in CORO7 knockout cells may be the cause for the defective
targeting if the core kinase cassette formation is a prerequisite for
the membrane association of the cassette.
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Although CORO7 appears to be a critical regulator of the Hippo
pathway, upstream molecules that control the function of CORO7
remain unknown. Other members of Coronin protein family bind actin
and modulate actin-dependent processes (Chan et al., 2011).
Furthermore, it has been reported that CORO7 regulates Golgi
morphology and trafficking which are linked to the actin cytoskeleton
(Yuan et al., 2014). Despite the controversy over the binding between
mammalian CORO7 and actin(Chan et al., 2011), actin might be a
potential regulator of CORO7 in the context of Hippo signaling. It is
worth noting that CORO7 is necessary for Hippo signaling activation
by serum deprivation, contact inhibition and Latrunculin B treatment
which are stimuli thought to be mediated by actin cytoskeleton.
Interestingly, the actin cytoskeleton dynamics is thought to be
involved in Hippo signaling activation by all of these stimuli (Gaspar
and Tapon, 2014; Panciera et al., 2017). Considering the wide range of
Hippo upstream signals to which CORO7 can response, CORO7 may
sense actin cytoskeleton remodeling to regulate Hippo signaling.
Therefore, further research confirming the possibility that actin
cytoskeleton is the direct upstream regulator of CORO7 is necessary
for the thorough understanding of Hippo signaling regulation by
CORO7.
Taken together, I demonstrate that CORO7 is an evolutionarily
conserved member of the Hippo pathway. Despite extensive studies
which have tried to understand Hippo signaling regulation, how and
where various upstream stimuli including growth factor, mechanical
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cues and cell attachment converge on Hippo core components possibly
through the actin cytoskeleton remain elusive. Thus, further studies
on precise integration mechanism of the Hippo pathway will be
significant for the understanding of the physiological regulation of the
signaling and offer insights into more effective therapeutic strategies




HEK293T and MDA-MB-231 cells were maintained in DMEM
containing 10% fetal bovine serum. For serum deprivation, LatB (0.25 
μg/ml) treatment and cell detachment experiments, cells were seeded
to low confluency (less than 30%). Plasmids were transfected with
the polyethylenimine reagent. HEK293T and MDA-MB-231 cells
were kindly provided by J Blenis and DS Lim, respectively.
Expression constructs and RNAi experiments
The mammalian expression plasmids for human LATS1/2, MST1/2,
SAV1, MOB1A, KIBRA, AMOT p80, AMOTL1, AMOTL2 were kind
gifts from DS Lim. CORO7 plasmid was purchased from Sino
Biological and cloned in pcDNA3 HA and pcDNA3.1 Flag vector.
Plasmids for truncated forms of genes were generated by PCR and
cloned in pcDNA3.1 HA- or pcDNA3.1 Flag expression vectors.
LATS1 truncated mutants were kind gifts from NG Kim. All SAV1
and CORO7 mutants were made by site-directed mutagenesis. All of
the constructs generated were confirmed by DNA sequencing. For
RNAi experiments, cells were treated with indicated siRNA for 72 h
using RNAiMAX reagent (Thermo Fisher Scientific) and collected for
further examination. Decreased expression of the target protein was




Cells were lysed in lysis buffer (150 mM NaCl, 20 mM Tris, pH 7.4,
1 mM EGTA, 1 mM EDTA, 1% NP-40, 2.5 mM sodium
pyrophosphate, 1 mM Na3VO4, 10% glycerol and protease inhibitors).
Equivalent protein quantities were subjected to SDS–PAGE, and
transferred to nitrocellulose membranes. Membranes were blocked
with 5% BSA for 1 h at room temperature and then probed with the
indicated primary antibodies, followed by the appropriate
HRP-conjugated anti-mouse/rabbit secondary antibodies (Jackson
ImmunoResearch). Immuno-reactive bands were visualized with ECL.
Immunoprecipitation
Cells were collected and lysed in 0.5 ml lysis buffer plus protease
inhibitors (Pepstatin A, PMSF and Leupeptin) for 30 min at 4 °C.
After 12,000g centrifugation for 15 min, the lysates were
immunoprecipitated with 2 μg specific antibody overnight at 4 °C,
and 30 μl A/G agarose beads were washed and then added for an
additional 1 h. Thereafter, the precipitants were washed five times
with lysis buffer, and the immune complexes were boiled with SDS
loading buffer for 5 min and analysed by SDS–PAGE. The
following antibodies were used for IP: HA (MBL life science,
M132-3), Flag (MBL life science, M185-3L), myc (MBL life science,
M192-3), CORO7 (Abcam, ab117446), YAP (Santa-Cruz, sc-101199),




Cells were seeded on coverslips. Cells were fixed with 4%
paraformaldehyde for 10 min at room temperature, and then
permeabilized with 0.1% Triton X-100. After blocking in goat serum
for 1 h, slides were incubated with primary antibody for 1 h at room
temperature or at 4 °C overnight, washed 3 times with PBS, and
then incubated with FITC- or TRITC-conjugated secondary
antibodies (Invitrogen, 1:1,000) and DAPI for 1 h at room
temperature. Antibodies against YAP (1:100, sc-101199) were used
for immunofluorescence. The slides were then washed 3 times with
PBS and mounted. Cell images were captured with a confocal
microscope (Zeiss).
RNA isolation and real-time PCR
Total RNA was isolated from cultured cells using Trizol reagent.
cDNA was synthesized by reverse transcription using oligo (dT) and
subjected to real-time PCR with CTGF, CYR61, and ACTB primers
in the presence of Cyber green PCR-Mix (Bioneer). Relative
abundance of mRNA was calculated by normalization to ACTB
mRNA. The following primer pairs were used to detect the mRNA







-CTCCTTAATGTCACGCACGAT-3′). Data were analysed from five
independent experiments and are shown as the average mean ±
s.e.m.
CRISPR
CRISPR genomic editing technology was used for the deletion of
CORO7. The guide RNA sequences were cloned into the plasmids
px459 (addgene 62988) purchased from Addgene. The constructed
plasmids were transfected into MDA-MB-231 cells. 24 h after
transfection, the transfected cells were enriched by 1 μg ml−1
puromycin selection for 2 days and then were sorted onto 96-well
plates with only one cell in each well. The clones were screened by
Western blot with gene-specific antibodies. The guide RNA
sequences were 5’-CACCGGCTTCAGGGTGTCCAAGTTC-3’.
Luciferase assay
MDA-MB-231 cells were cultured in 6‐well dishes and transfected
with 0.4μg 8X‐TBS luciferase, 20 ng pRL-TK using
Lipofectamine3000. Reporter activities were measured using a Dual
Luciferase Kit (Promega) according to the manufacturer's guides.
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초파리에서부터 인간에 이르기까지 Hippo 신호전달체계는 기관
의 성장과 조직 항상성의 유지에 중요한 역할을 수행한다. 지난 20여 년
간의 활발한 연구를 통해 두 인산화효소 (MST1/2 와 LATS1/2)와 두
scaffold (SAV1 and MOB1)로 구성된 중심 인산화효소 복합체가 Hippo
신호전달체계를 조절하는 데 필수적이라는 것이 밝혀졌다. 하지만 우리
는 이 복합체가 어디에서 어떻게 형성되고 활성화되는지 충분히 이해하
지 못한다. 이 연구에서 나는 단백질 상호작용 데이터베이스 분석과 초
파리 유전자 스크리닝을 통해 CORO7이 Hippo 신호전달체계를 양성적
으로 조절한다는 것을 밝혔다. 포유동물 세포에서 CORO7이 혈청 부족,
세포 간 접촉 그리고 세포골격 손상에 의해 Hippo 신호전달체계가 활성
화되는데 필요하다는 결과를 통해 CORO7이 여러 상위 신호를 인지하여
Hippo 신호전달체계를 조절한다는 것을 규명하였다. 또한 나는 CORO7
이 Hippo 신호전달체계 구성요소들과 물리적으로 결합한다는 것과 중심
42
인산화효소 복합체 형성을 위한 scaffold 역할을 한다는 것을 보였다. 특
히, SAV1-MST2와 CORO7의 결합이 Hippo 신호전달체계의 상위 신호
에 의해 조절된다는 것을 보여줌으로써 CORO7이 순차적인 중심 인산화
효소 복합체 구성요소들 사이의 상호작용을 조절한다는 것을 발견했다.
이번 결과는 Hippo 신호전달체계의 조절에 대한 분자적 기작과 Hippo
신호전달체계와 관련된 인간 질병을 더욱 깊게 이해하는 데 기여할 것이
다.
주요어: CORO7, Hippo 신호전달체계, scaffold, 단백질 상호작용
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